Keywords: آنتی ترومبین III; ACT; activated clotting time; APTT; activated partial thromboplastin time; ATAD; acute thoracic aortic dissection; AT-III; antithrombin III; COPD; chronic obstructive pulmonary disease; CPB; cardiopulmonary bypass; CRP; C-reactive protein; CTAD; chronic t
مقالات ISI آنتی ترومبین III (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ترومبین III; AHA/ACC; American Heart Association/American College of Cardiology; APTT; active partial thromboplastin time; AR chip; chip for mixed white thrombus analysis; ATIII; antithrombin III; AUC; area under the flow pressure curve; DAP; diastolic arterial blood
Keywords: آنتی ترومبین III; ADP; adenosine diphosphate; APC; activated protein C; AT-III; antithrombin III; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; CLP; cecal ligation - perforation; DIC; disseminated intravascular coagulation; LPS; lipopolysaccharide; IL-
Keywords: آنتی ترومبین III; Amax; maximal thrombin concentration; APTT; activated partial thromboplastin time; AT; antithrombin III; CVerror; relative random error of measurement; CVii; inter-individual coefficient of variability; CVtotal; total coefficient of variation; ETP; endoge
Keywords: آنتی ترومبین III; ICUs; intensive care units; DIC; disseminated intravascular coagulation; SIRS; systemic inflammatory response syndrome; ROS; reactive oxygen species; APACHE II; Acute Physiology and Chronic Health Evaluation II; SOFA; Sequential Organ Dysfunction Assessme
Keywords: آنتی ترومبین III; ADP; adenosine diphosphate; Apo; apolipoprotein; AT III; antithrombin III; AUC; area under the curve; BMI; body mass index; CET; cholesterol ester transfer; CRP; C-reactive protein; CVD; cardiovascular disease; FMD; flow mediated dilation; FVII; factor VI
Keywords: آنتی ترومبین III; Novel oral anticoagulant; Atrial fibrillation; Antithrombin III; Protein C/S;
Keywords: آنتی ترومبین III; CVT; cerebral venous thrombosis; PAI-1; plasminogen activator inhibitor â 1; PC; protein C; PS; protein S; AT; antithrombin III; FVL; Factor V Leiden; tPA; tissue plasminogen activator; PLG; plasminogen; A2-AP; alpha-2-antiplasmin; APLA; antiphospholip
Keywords: آنتی ترومبین III; Babesiosis; Coagulation; Antithrombin III; Protein C pathway;
Capillary electrophoresis in the context of drug discovery
Keywords: آنتی ترومبین III; ACE; affinity capillary electrophoresis; AGP; α-acid glycoprotein; AH; adrenaline hydrochloride; AIμEA; automatic micro-enzyme assay; AL; amlodipine; AT; antithrombin III; Bag3; Bcl2-associated anthanogene 3; BGE; background electrolyte; CM; chylomicron
Keywords: آنتی ترومبین III; glycosaminoglycans; bioanalysis; processing; LC-MS; NMR spectroscopy; molecular weight determination; heparin; enoxaparin; bovine lung; porcine intestine; ATIII; antithrombin III; BLE; bovine lung heparin-derived enoxaparin; ESI; electrospray ionization
Keywords: آنتی ترومبین III; ACTH; adrenocorticotroph; AFLP; acute fatty liver of pregnancy; aOR; adjusted odds ratio; ARR; aldosterone:renin ratio; ATIII; Antithrombin III; CAPS; catastrophic antiphospholipid syndrome; CPAP; continuous positive airway pressure; CS; Cushing's syndr
Keywords: آنتی ترومبین III; Antithrombin III; Disseminated intravascular coagulation; Sepsis; Anticoagulant agents; Consumption coagulopathies;
Keywords: آنتی ترومبین III; Prothrombotic; Hypercoagulable; Stroke; Factor V Leiden; Prothrombin mutation; Antithrombin III; Antiphospholipid antibodies; Homocysteine;
Keywords: آنتی ترومبین III; cardiopulmonary bypass; unfractionated heparin; whole-blood-activated coagulation time; heparin resistance; antithrombin III
Keywords: آنتی ترومبین III; LPS; Antithrombin III; ApoA-I; ApoA-II; HDL;
Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery
Keywords: آنتی ترومبین III; anticoagulation; heparin; bleeding; thrombosis; congenital heart disease; Anti-Xa; anti-factor Xa activity; aPTT; activated partial thromboplastin time; ATIII; antithrombin III; CI; confidence interval; CICU; cardiac intensive care unit; IQR; interquartil
N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes
Keywords: آنتی ترومبین III; ACD; citrate-dextrose solution; APC; activated protein C; ATIII; antithrombin III; FITC; fluorescein isothiocyanate; Glo; glyoxalase; GPx-1; glutathione peroxidase-1; GSH; glutathione; GSSG; glutathione disulfide; MG; methylglyoxal; NAC; N-acetylcysteine;
Novel method for measurement of heparin anticoagulant activity using SPR
Keywords: آنتی ترومبین III; Anticoagulant activity; Heparin; SPR; Antithrombin III;
Original ArticleOutcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation
Keywords: آنتی ترومبین III; Neonatal; ECMO; Antithrombin III; Coagulation; Thrombosis; Bleeding;
Antithrombin III Protects Against Contrast-Induced Nephropathy
Keywords: آنتی ترومبین III; Antithrombin III; Acute kidney injury; Contrast induced nephropathy; Inflammation;
Invited PerspectiveEffects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials
Keywords: آنتی ترومبین III; Antithrombin III; Fibrinogen; Postmenopausal women; Tibolone;
Low-Density Lipoprotein Receptor-Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction
Keywords: آنتی ترومبین III; ischemia reperfusion; low-density lipoprotein receptor-related protein-1; serine protease inhibitor; SERPINs; A2MG; alpha-2 macroglobulin; AAT; alpha-1 antitrypsin; AMI; acute myocardial infarction; ATIII; antithrombin III; HRP; horseradish peroxidase; IL
Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants
Keywords: آنتی ترومبین III; antithrombin-binding site; heparin-derived tetrasaccharides; anticoagulant activity; heparin lyase; structure-activity relationship; AT; antithrombin III; UA; uronic acid; IdoA; iduronic acid; GlcA; β-D-glucuronic acid; GlcN; α-d-glucosamine; STs; sulfo
Analytical and statistical comparability of generic enoxaparins from the US market with the originator product
Keywords: آنتی ترومبین III; AT; antithrombin; ATIII; antithrombin III; BSA; bovine serum albumin; CNBr; cyanogen bromide; CTA; cetyltrimethylammonium; CZE; capillary zone electrophoresis; EMA; European Medicines Agency; FDA; US Food and Drug Administration; Gal; galactose; GlcA; glu
A novel polymorphism in the PAI-1 gene promoter enhances gene expression. A novel pro-thrombotic risk factor?
Keywords: آنتی ترومبین III; PAI-1; plasminogen activator inhibitor-1; SERPIN; serine protease inhibitors; t-PA; tissue-type plasminogen activator; u-PA; urokinase-type plasminogen activator; USF-1; upstream stimulatory factor-1; ATIII; antithrombin III; HPA-1; human platelet antigen
The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III
Keywords: آنتی ترومبین III; Antithrombin III; Hypercoagulability; Diabetes; Methylglyoxal;
Controllable production of low molecular weight heparins by combinations of heparinase I/II/III
Keywords: آنتی ترومبین III; HIT; heparin-induced thrombocytopenia; LMWHs; low molecular weight heparins; HepI; heparinase I; HepII; heparinase II; HepIII; heparinase III; GlcNS6S; 6-O-sulfo-N-sulfo-α-d-glucosamine; GlcNS3S6S; 3,6-di-O-sulfo-N-sulfo-α-d-glucosamine; IdoA2S; 2-O-sul
Original scientific articleOptimizing Risk Stratification in Portal Vein Thrombosis after Splenectomy and its Primary Prophylaxis with Antithrombin III Concentrates and Danaparoid Sodium in Liver Cirrhosis with Portal Hypertension
Keywords: آنتی ترومبین III; ATIII; antithrombin III; HCV; hepatitis C virus; IFN; interferon; LMWH; low-molecular weight heparin; POD; postoperative day; PVT; portal vein thrombosis; ROC; receiver operating characteristic; SVD; splenic vein diameter; UFH; unfractionated heparin; US;
Decreased thrombin activity by a Congolese herbal medicine used in sickle cell anemia
Keywords: آنتی ترومبین III; Ceiba pentandra (L.) gaertn; Quassia africana baill; Sickle cell anemia; Thrombin; Antithrombin III; Plasma clotting time;
Bioequivalence of Two Intravenous Formulations of Antithrombin III: A Two-Way Crossover Study in Healthy Korean Subjects
Keywords: آنتی ترومبین III; antithrombin III; bioequivalence; pharmacokinetic equivalence; pharmacokinetics;
Sequence, phylogenetic and variant analyses of antithrombin III
Keywords: آنتی ترومبین III; Antithrombin III; SerpinC1; Group V5; Synteny; Phylogenetic analysis; ATIII variants;
Congenital disorder of glycosylation type Ic: Report of a Japanese case
Keywords: آنتی ترومبین III; Congenital disorder of glycosylation; CDG-Ic; ALG6; Glucosyltransferase; Transferrin; Psychomotor retardation; Antithrombin III
Antithrombin III administration in neonates with congenital diaphragmatic hernia during the first three days of extracorporeal membrane oxygenation
Keywords: آنتی ترومبین III; ATIII; Antithrombin III; Extracorporeal membrane oxygenation; ECMO; Neonate; Congenital diaphragmatic hernia; Blood product
Hypercoagulability Markers Predict Thrombosis in Single Ventricle Neonates Undergoing Cardiac Surgery
Keywords: آنتی ترومبین III; 21; ATIII; antithrombin III; CI; confidence interval; CPB; cardiopulmonary bypass; FVIII; factor VIII; ICU; intensive care unit; LOS; length of stay; PAI-1; plasminogen activator inhibitor; PC; protein C; PPP; platelet poor plasma; PS; protein S; RFU; rel
Structural Characterization of Pharmaceutical Heparins Prepared from Different Animal Tissues
Keywords: آنتی ترومبین III; bioanalysis; glycosaminoglycans; heparin; LC-MS; NMR; mass spectomery; surface plasmon resonance; antithrombin III;
An Antithrombin III product containing biologically active hepatocyte growth factor may be beneficial in deep ulcer infections
Keywords: آنتی ترومبین III; Antithrombin III; Biological activity; Deep ulcer infection; Hepatocyte growth factor;
Recombinant mitochondrial transcription factor A protein inhibits nuclear factor of activated T cells signaling and attenuates pathological hypertrophy of cardiac myocytes
Keywords: آنتی ترومبین III; mtDNA; mitochondrial DNA; ROS; reactive oxygen species; TFAM; mitochondrial transcription factor A; MI; myocardial infarction; NFAT; nuclear factor of activated T cells; GST; glutathione S-transferase; MTS; mitochondrial targeting signal; rhTFAM; recombin
Antithrombotic and profibrinolytic activities of phloroglucinol
Keywords: آنتی ترومبین III; aPTT; activated partial thromboplastin time; AT III; antithrombin III; ERK; extracellular signal-regulated kinase; FX; factor X; JNK; c-Jun N-terminal kinase; NF-κB; nuclear factor factor-κB; PAI-1; plasminogen activator inhibitor type 1; PT; prothrombi
Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke
Keywords: آنتی ترومبین III; Antithrombin III; Fibrinogen; Ischemic stroke; Acute
Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery
Keywords: آنتی ترومبین III; 23.1; 25; 28; 37; ACT; activated clotting time; APTT; activated partial thromboplastin time; AT; antithrombin III; CABG; coronary artery bypass grafting; CPB; cardiopulmonary bypass; FDPs; fibrinogen degeneration products; IL; interleukin; OPCAB; off-pump
Impact of Autoclave Sterilization on the Activity and Structure of Formulated Heparin
Keywords: آنتی ترومبین III; heparin; surface plasmon resonance; antithrombin III; thrombin; interaction; stability; autoclaving; NMR; LCâMS; PAGE;
Purification and partial characterization of antithrombin III from bovine skeletal muscle and possible role of thrombin in postmortem apoptosis development and in efficiency of low voltage electrical stimulation
Keywords: آنتی ترومبین III; Antithrombin III; Thrombin; Bovine muscle; Purification procedure; Apoptosis; Low voltage electrical stimulation (LVES)
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer
Keywords: آنتی ترومبین III; AT; antithrombin III; ECM; extracellular matrix; FGF1; fibroblast growth factor-1; FGF2; fibroblast growth factor-2; FGFR; fibroblast growth factor receptor; GAG; glycosaminoglycan; GlcA; glucuronic acid; GlcNAc; N-acetyl glucosamine; GlcNSO3; glucosamine
Epidemiology and Risk Factors for Thromboembolic Complications of Childhood Nephrotic Syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) Study
Keywords: آنتی ترومبین III; APL; Antiphospholipid antibodies/lupus anticoagulant; AT3; Antithrombin III; CI; Confidence interval; CVAD; Central venous access device; DVT; Deep venous thrombosis; FVL; Factor V Leiden; MN; Membranous nephropathy; NS; Nephrotic syndrome; OR; Odds ratio
Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study
Keywords: آنتی ترومبین III; Vicoelastic property; Morphology; Fibrin; Heparin; Antithrombin III; QCM-Z; AFM
Laboratory Evaluation of Hypercoagulability
Keywords: آنتی ترومبین III; Protein C; Protein S; Antithrombin III; Activated protein C resistance; Factor V Leiden; Prothrombin G20210A; Antiphospholipid antibodies
In situ growth of nanogold on quartz crystal microbalance and its application in the interaction between heparin and antithrombin III
Keywords: آنتی ترومبین III; In situ growth; Nanogold; Quartz crystal microbalance; Heparin; Antithrombin III
Overexpression of GADD34 Enhances Production of Recombinant Human Antithrombin III in Chinese Hamster Ovary Cells
Keywords: آنتی ترومبین III; Chinese hamster ovary cells; GADD34; antithrombin III
Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells
Keywords: آنتی ترومبین III; Chinese hamster ovary cells; fucosylation; small interfering RNA; antithrombin III; GDP-fucose transporter